Cited by 55Liver Disease Diagnosis and TreatmentThyroid Disorders and TreatmentsLipid metabolism and disorders

Increased Hepatic Fat Content in Patients with Resistance to Thyroid Hormone Beta

Open access
Chaves, Carolina, Bruinstroop, Eveline, Refetoff, Samuel, Yen, Paul M., Anselmo, João·2021·Thyroid®

Abstract

Background: Thyroid hormone (TH) has important functions in controlling hepatic lipid metabolism. Individuals with resistance to thyroid hormone beta (RTHβ) who harbor mutations in the THRB gene experience loss-of-function of thyroid hormone receptor beta (TRβ), which is the predominant TR isoform expressed in the liver. We hypothesized that individuals with RTHβ may have increased hepatic steatosis. Methods: Controlled attenuation parameter (CAP) was assessed in individuals harboring the R243Q mutation of the THRB gene ( n = 21) and in their wild-type (WT) first-degree relatives ( n = 22) using the ultrasound-based transient elastography (TE) device (FibroScan). All participants belonged to the same family, lived on the same small island, and were therefore exposed to similar environmental conditions. CAP measurements and blood samples were obtained after an overnight fast. The observers were blinded to the status of the patients. Results: The hepatic fat content was increased in RTHβ individuals compared with their WT relatives (CAP values of 263 ± 21 and 218.7 ± 43 dB/m, respectively, p = 0.007). The CAP values correlated with age and body mass index (BMI) (age: r = 0.55, p = 0.011; BMI: r = 0.51, p = 0.022) in the WT first-degree relatives but not in RTHβ individuals, suggesting that the defect in TRβ signaling was predominant over the effects of age and obesity. Circulating free fatty acid levels were significantly higher in RTHβ individuals (0.29 ± 0.033 vs. 0.17 ± 0.02…

Integrity signals

Registry

Crossref · 10.1089/thy.2020.0651

Cites

0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In patients with resistance to thyroid hormone, the opposite effect on intrahepatic lipid content is observed.

    “Indeed, low-dose LT4 reduces intrahepatic lipid content in patients with type 2 diabetes mellitus and metabolic (dysfunction)-associated fatty liver disease (77), whereas the opposite is observed in patients with resistance to TH (78).”

    From Emerging Therapies in Hypothyroidism (2024) · cites this paper as [78]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Chaves, C., Bruinstroop, E., Refetoff, S., Yen, P. M., & Anselmo, J.
Affiliations
  • Hospital do Divino Espírito Santo (PT)
  • Duke-NUS Medical School (SG)
  • University of Chicago (US)
  • Duke University (US)
Corresponding author
Anselmo, João
Venue
Thyroid®
Published
2021-07
Volume
31
Issue
7
Pages
1127-1134
ISSN
  • 1050-7256 (ISSN-L)
  • 1557-9077
OpenAlex
W3113999992
Cited by
55
References
39
Citations by year
2026: 10 · 2025: 13 · 2024: 20 · 2023: 5 · 2022: 6 · 2021: 1
FWCI
2.15
Type
journal article
Language
en
Open access
Locations
  • Thyroid (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • Pure Amsterdam UMC (publishedVersion)
  • Data Archiving and Networked Services (DANS) (submittedVersion)
Funders
National Institute of Diabetes and Digestive and Kidney Diseases (R01DK015070)
Topics
  • Health Sciences › Medicine › Epidemiology › Liver Disease Diagnosis and Treatment
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
Keywords
resistance to thyroid hormone beta, THRB gene, thyroid hormone receptor beta, hepatic steatosis, hepatic fat content, controlled attenuation parameter, transient elastography, free fatty acids, hepatic lipid metabolism, insulin resistance, non-alcoholic fatty liver disease, thyromimetics, first-degree relatives
MeSH terms
Adipose Tissue, Adolescent, Adult, Fatty Liver, Female, Humans, Insulin Resistance, Liver, Male, Middle Aged, Mutation, Thyroid Hormone Resistance Syndrome, Thyroid Hormone Receptors beta, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review